Equities

Latitude Financial posts 39% H1 2026 profit rise, declares AUD 0.055 dividend
Half-year cash profit surged 39% to AUD 64.3 million as receivables topped AUD 7.3 billion. Interim dividend set at AUD 0.055 per share, fully franked.
Morgan Stanley lifts semiconductor equipment outlook on stronger DRAM demand
Analysts raise 2026 and 2027 wafer fabrication equipment forecasts as DRAM investment accelerates. Advantest remains top pick after raising guidance.

Ascelia Pharma shares surge 8.2% after FDA setback on Orviglance
Swedish biotech advances despite Complete Response Letter on lead MRI contrast agent; cash runway extended into Q2 2027 after cost cuts.

Nanoform cuts Q2 2026 cash burn to EUR 1.5m as regulatory progress accelerates
Finnish drugmaker trims first-half spending by 33% year-on-year while securing $1m deal and advancing nanoenzalutamide toward market authorization.

Clavister posts 63% sales growth, record 30% EBITDA margin in Q2 2026
Swedish cybersecurity firm Clavister reported a 63% year-over-year surge in net sales to 89.2 million Swedish kronor, alongside a record 30% adjusted EBITDA margin. Defence segment revenue surged 370% to 47 million kronor.

Gubra reports H1 2026 profit rebound, obesity pipeline progress
Danish biotech firm returns to profit in H1 2026 as CRO arm grows, while obesity pipeline advances with Phase 2 milestones and new drug candidates.

Swiss ETF savings plans surge 44.6% in H1 2026, led by global index funds
Broadly diversified world ETFs dominate Swiss savings plans despite AI and ESG hype, with monthly volume up 29% in Europe. Swiss adoption remains low at 9% of investors.

Accent Group posts A$13.8m loss, unveils FY2026 strategic reset
Australian footwear retailer Accent Group reported a statutory net loss of A$13.8m for FY2026 while outlining a multi-year portfolio overhaul targeting A$40m in cost savings and A$14m EBIT lift by 2030.

HKEX posts record profit on 19% revenue rise in first half of 2026
Hong Kong Exchanges and Clearing reported HK$16.7 billion in revenue and HK$10.6 billion in net profit for the first half of 2026, driven by strong trading volumes and derivatives activity. Interim dividend increased 24% to HK$7.43 per share.

Karnov shares surge 12.86% on Q2 2026 results, AI-driven margin gains
Karnov Group reported a 25% adjusted EBITA margin in Q2 2026, up from 23%, as its AI workflow launch boosted profitability. Shares jumped 12.86% in pre-market trading on the news.

Höegh Autoliners Q2 2026 profit falls 17% as fuel costs surge
Car carrier operator posts $86 million net profit despite 2.6% volume growth and $22 million fuel cost hit. Shares drop 12.6% after results.

Scatec Q2 2026 results: Obelisk project offsets revenue decline
Renewable energy developer reports 10% drop in EBITDA but cites Africa's largest hybrid project as key offset to flat revenues. Power production rises 21% year-over-year.
Nscale plans $3 bln US IPO as AI data center demand surges
London-based AI data center firm Nscale targets September listing to raise up to $3 billion, citing $51 bln in contracted revenue and 10 GW of planned power capacity.

HKEX posts record H1 2026 profit on trading surge, dividend hike
Hong Kong Exchanges and Clearing reported a 24% rise in H1 2026 profit as trading volumes hit records, with EPS beating estimates by 18%. First interim dividend raised to HKD 7.43 per share.
Karnov Group shares surge 12.9% on AI workflow rollout, Q2 profit beats
Swedish legal data provider Karnov Group posted a 2.4% organic sales increase in Q2 2026, with adjusted EBITA margin rising to 25% as its AI-driven workflow solution drove customer upgrades. Shares jumped 12.9% following the release.

U.S. stocks face midterm election jitters as 2018, 2022 patterns resurface
Historical midterm election years show S&P 500 volatility in late summer and fall, with sector rotations offering clues for 2026. RBC Capital Markets expects contained pullbacks unless recession or rate risks escalate.

Novonesis shares surge 9% after Q2 results, higher 2026 guidance and €1bn buyback
Danish biosolutions firm posts 9% organic sales growth in Q2, beats estimates, raises 2026 outlook and launches inaugural €1bn share repurchase program.

Panoro Energy shares drop 4% after H1 2026 update, CI-27 deal details emerge
Panoro Energy’s stock fell 4% in pre-market trading after releasing H1 2026 pro forma figures and confirming a $80 million acquisition in Ivory Coast. The CI-27 deal, funded via shares and debt, is expected to close by Q3.

Zelluna shares fall 3.6% after Q2 2026 clinical update
Norway-based biotech’s stock declines after first patient dosed in ZIMA-101 trial; cash runway extends into Q3 2027. CEO cites ‘defining’ quarter as trial advances.

Novonesis lifts 2026 outlook, shares surge 8.5% on earnings update
The Danish biosolutions firm raised its full-year organic growth target to 7%-8% and announced a €1 billion buyback program through 2029. Shares jumped 8.5% to $449.50 amid strong H1 sales and EBITDA growth.

BMO reshuffles international capital markets leadership amid global expansion
Richard Couzens to lead unified international capital markets unit, while Chris Taves prepares to retire in 2027. Restructuring follows BMO’s push into EMEA and Asia.

EverBank explores sale process after 2023 private-equity buyout
Digital lender with $47 billion in assets weighs strategic options including sale or IPO. Private-equity owners acquired it from TIAA in 2023.

Swiss stocks edge higher as Roche, Novartis offset losses; Logitech slides
SMI gains 0.1% as healthcare giants support index; Logitech drops 1.3% after JP Morgan downgrade. Oil holds near $92, gold dips as yields fall.

German DAX slips 0.34% in early trade as oil, yields weigh
European stocks opened lower Thursday as rising oil prices and bond yields pressured the DAX, while gains in Continental and Sartorius were offset by losses in Brenntag and Ströer.

